Resolute Capital Asset Partners »

Protagonist Therapeutics shares owned by Resolute Capital Asset Partners

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Resolute Capital Asset Partners from 13F filings

Historical chart of Resolute Capital Asset Partners investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Resolute Capital Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Resolute Capital Asset Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.1M 40k 28.94
2021-12-31 $1.9M 55k 34.20

More positions owned by Resolute Capital Asset Partners

Amazon (AMZN)
Aercap Holdings Nv Ord Cmn (AER)
Facebook Inc cl a (META)
Archer Daniels Midland Company (ADM)
Api Group Corp (APG)
Allstate Corporation (ALL)
Ftai Aviation (FTAI)
Ascendis Pharma A S (ASND)
Sap (SAP)
Crane Company (CR)
Autoliv (ALV)
General Electric (GE)
Square Inc cl a (SQ)
Citigroup (C)
Okta Inc cl a (OKTA)

View all positions for Resolute Capital Asset Partners

Top funds holding Protagonist Therapeutics

Farallon Capital Management
BlackRock
BVF
Vanguard Group
Johnson & Johnson
Adage Capital Partners GP
Morgan Stanley
Cowen And Company
Geode Capital Management
Point72 Asset Management
Leucadia National Corporation
Kynam Capital Management
Perceptive Advisors
Marshall Wace
Fairmount Funds Management

View all funds holding Protagonist Therapeutics